Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05949008 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 30, 2027 to Oct 30, 2027
    • Study completion date: Jul 30, 2027 to Jul 30, 2028
    v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints: 5 to 11
    • Site details revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2023 to Nov 22, 2023
    • Site details revised
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Metformin is a drug used to treat patients with diabetes. The aim of this study is to examine the effect of Metformin along with a low-calorie diet on obese and/or overweight adults with an increased waist measurement. In addition, the study also aims to look at the effect of the drug vs. placebo on quality of life and physical activity.
Trial Details
NCT Number NCT05949008
Lead Sponsor University of California, Los Angeles
Conditions
(from sponsor)		 NIDDM, Obesity
Related terms Diabetes Mellitus, Type 2, Obesity
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov